BLOODPAC’s Executive Director, Lauren Leiman, will participate in the Hanson Wade 5th Liquid Biopsy for Precision Oncology Summit East Coast. BLOODPAC’s session will take place on Wednesday, July 22, 2026, from 11:30 AM–12:00 PM ET.

Titled “Building Global Consensus for Liquid Biopsies to Drive Universal Clinical Integration,” the session will explore:

• Aligning stakeholders—including diagnostic developers, biopharma, and consortia—on assay performance and interpretation

• Reducing variability through shared standards and best practices, including standardized parameters

• Enabling broader clinical integration through harmonized approaches

You can access the event website here.